跳至主要内容
临床试验/NL-OMON36495
NL-OMON36495已完成4 期

Pharmacokinetics of the addition of an acidic beverage to posaconazole co-administered with a proton pump inhibitor in GVHD patients - Pharmokinetics of cola addition to posaconazol and PPI in GVHD

Vrije Universiteit Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • *recipients of hematopoietic stem-cell transplantation (HSCT) with graft versus host disease (GVHD) using PPI
  • *start or use of posaconazole for invasive fungal infection (IFI) prophylaxis with concomitant PPI use for at least twelve days or one week when already using posaconazole

排除标准

  • *current clinical significant invasive fungal infection requiring treatment
  • *inability to sign informed consent
  • *inability to take oral medication
  • *allergy to posaconazole, PPI or the acidic beverage
  • *start or discontinuation of a CYP3a4 inhibitor or P-glycoprotein inducer during the study period
  • *age < 18 years
  • *grade II or more diarrhea, mucositis, vomiting

研究者

相似试验